|
US488064A
(en)
|
|
1892-12-13 |
|
Magnetic separator |
|
US3108097A
(en)
|
|
1963-10-22 |
|
Ehnojs |
|
US2809194A
(en)
|
|
1957-10-08 |
|
Thiadiazine type natriuretic agents |
|
US51091A
(en)
|
|
1865-11-21 |
|
Thomas shedd and feedeick glocknee |
|
FR1103113A
(fr)
|
1954-04-15 |
1955-10-31 |
|
Triméthylol-alcanes et leur procédé de préparation
|
|
DE1116676B
(de)
|
1955-03-14 |
1961-11-09 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
|
|
FR1217929A
(fr)
|
1958-03-03 |
1960-05-06 |
Ciba Geigy |
Procédé de préparation du 1,1-dioxyde de la 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine et de ses sels
|
|
BE578515A
(pl)
|
1958-05-07 |
|
|
|
|
DE1302648B
(pl)
|
1960-09-27 |
|
|
|
|
NL281975A
(pl)
|
1961-08-12 |
|
|
|
|
GB1051218A
(pl)
|
1963-03-09 |
|
|
|
|
NL127065C
(pl)
|
1964-04-22 |
|
|
|
|
NL137318C
(pl)
|
1964-06-09 |
|
|
|
|
GB1078852A
(en)
|
1964-09-30 |
1967-08-09 |
Ici Ltd |
Alkanolamine derivatives
|
|
US3466325A
(en)
|
1965-04-30 |
1969-09-09 |
Haessle Ab |
1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
|
|
US3636039A
(en)
|
1970-02-24 |
1972-01-18 |
Hoffmann La Roche |
Substituted benzylimidazolidinones
|
|
GB1361441A
(en)
|
1970-05-13 |
1974-07-24 |
Sandoz Ltd |
Benzonaphthyridine derivatives
|
|
US4059622A
(en)
|
1970-05-27 |
1977-11-22 |
Imperial Chemical Industries Limited |
Alkanolamine derivatives
|
|
GB1338235A
(en)
|
1970-12-15 |
1973-11-21 |
May & Baker Ltd |
Azapurinones
|
|
DE2117571C3
(de)
|
1971-04-10 |
1979-10-11 |
Bayer Ag, 5090 Leverkusen |
Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
|
|
BE794964A
(fr)
|
1972-02-04 |
1973-08-02 |
Bristol Myers Co |
Nouveaux agents hypotenseurs et procede pour les preparer
|
|
JPS5229318B2
(pl)
|
1972-03-30 |
1977-08-01 |
|
|
|
DE2305339C3
(de)
|
1973-02-03 |
1980-05-08 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
|
|
US4062950A
(en)
|
1973-09-22 |
1977-12-13 |
Bayer Aktiengesellschaft |
Amino sugar derivatives
|
|
AR205004A1
(es)
|
1973-10-30 |
1976-03-31 |
Ishikawa M |
Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
|
|
US4016166A
(en)
|
1973-12-14 |
1977-04-05 |
Hisamitsu Pharmaceutical Co., Inc. |
1-Nitrophenylquinazoline-2,4(1H,3H)-diones
|
|
AT334385B
(de)
|
1973-12-20 |
1976-01-10 |
Chemie Linz Ag |
Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen
|
|
DE2402908C2
(de)
|
1974-01-22 |
1982-12-02 |
Fa. Johann A. Wülfing, 4040 Neuss |
7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
|
|
DE2413935A1
(de)
|
1974-03-20 |
1975-10-16 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone
|
|
DE2521113A1
(de)
|
1974-05-15 |
1976-03-18 |
Maggioni & C Spa |
Cycloaliphatische derivate von 3.3-diphenylpropylamin
|
|
US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
|
US4046889A
(en)
|
1976-02-13 |
1977-09-06 |
E. R. Squibb & Sons, Inc. |
Azetidine-2-carboxylic acid derivatives
|
|
JPS608117B2
(ja)
|
1977-02-08 |
1985-02-28 |
財団法人微生物化学研究会 |
新生理活性物質エステラスチンおよびその製造法
|
|
DE2719912C3
(de)
|
1977-05-04 |
1979-12-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
|
|
NZ187452A
(en)
|
1977-06-10 |
1980-05-27 |
Otsuka Pharma Co Ltd |
N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
|
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
|
US4466972A
(en)
|
1977-06-20 |
1984-08-21 |
Sandoz Ltd. |
Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
|
|
NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
|
NO154918C
(no)
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
CA1114379A
(en)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phthalazines
|
|
JPS5953920B2
(ja)
|
1977-12-28 |
1984-12-27 |
東洋醸造株式会社 |
新規なアミノ糖化合物およびその製法
|
|
CA1121290A
(en)
|
1978-02-14 |
1982-04-06 |
Yasuji Suhara |
Amino sugar derivatives
|
|
JPS54148788A
(en)
|
1978-05-15 |
1979-11-21 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
|
|
US4316906A
(en)
|
1978-08-11 |
1982-02-23 |
E. R. Squibb & Sons, Inc. |
Mercaptoacyl derivatives of substituted prolines
|
|
JPS5527105A
(en)
|
1978-08-11 |
1980-02-27 |
Dai Ichi Seiyaku Co Ltd |
Imidazothienopyrimidinones compound
|
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
|
JPS5535019A
(en)
|
1978-09-01 |
1980-03-11 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
|
DE2845220A1
(de)
|
1978-10-17 |
1980-04-30 |
Yoshitomi Pharmaceutical |
Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
|
|
US4168267A
(en)
|
1978-10-23 |
1979-09-18 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl prolines
|
|
DE2847693A1
(de)
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
|
IL58849A
(en)
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
|
GB2063249A
(en)
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
|
JPS5671074A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
|
|
JPS5671073A
(en)
|
1979-11-12 |
1981-06-13 |
Takeda Chem Ind Ltd |
Imidazole derivative
|
|
NZ195564A
(en)
|
1979-11-26 |
1983-09-30 |
Sterling Drug Inc |
5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
|
|
DE2951135A1
(de)
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
|
US4344949A
(en)
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
|
ES505959A0
(es)
|
1980-10-09 |
1982-09-01 |
Hoechst Ag |
Procedimiento para la preparacion de un inactivador de alfa-amilasa
|
|
JPS5777676A
(en)
|
1980-10-31 |
1982-05-15 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivative
|
|
US4337201A
(en)
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
|
DE3166093D1
(en)
|
1981-01-05 |
1984-10-18 |
Takeda Chemical Industries Ltd |
N-substituted pseudo-aminosugars, their production and use
|
|
DE3107100A1
(de)
|
1981-02-20 |
1982-09-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Azaprostacycline, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
US4405628A
(en)
|
1981-03-05 |
1983-09-20 |
Merrell Dow Pharmaceuticals Inc. |
4-Pyridylimidazolones and method of use
|
|
DE3266746D1
(en)
|
1981-03-12 |
1985-11-14 |
Beecham Group Plc |
N-carboxyalkyl dipeptide derivatives and pharmaceutical compositions thereof
|
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
US4452813A
(en)
|
1981-05-22 |
1984-06-05 |
Taiho Pharmaceutical Company Limited |
Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
|
|
US4432971A
(en)
|
1981-08-03 |
1984-02-21 |
E. R. Squibb & Sons, Inc. |
Phosphonamidate compounds
|
|
CY1403A
(en)
|
1981-08-11 |
1987-12-18 |
Ciba Geigy Ag |
Benzazepin-2-ones
|
|
HU190412B
(en)
|
1981-09-17 |
1986-09-29 |
Warner-Lambert Co,Us |
Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
|
|
DE3226768A1
(de)
|
1981-11-05 |
1983-05-26 |
Hoechst Ag, 6230 Frankfurt |
Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
|
|
EP0080822A1
(en)
|
1981-11-27 |
1983-06-08 |
Beecham Group Plc |
Anti-hypertensive prolinol-based peptides
|
|
JPS5896052A
(ja)
*
|
1981-11-30 |
1983-06-07 |
Toyo Jozo Co Ltd |
高活性ｈ−ＰＴＨ（１−３４）アミドの製造法
|
|
EP0096517A3
(en)
|
1982-06-05 |
1985-04-03 |
Smith Kline & French Laboratories Limited |
Aryl pyrazinones
|
|
DE3368672D1
(en)
|
1982-06-14 |
1987-02-05 |
Ciba Geigy Ag |
Dyestuff preparation soluble in cold water
|
|
US4452790A
(en)
|
1982-06-23 |
1984-06-05 |
E. R. Squibb & Sons, Inc. |
Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
|
|
US4473575A
(en)
|
1982-07-19 |
1984-09-25 |
Ciba-Geigy Corporation |
3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
|
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
|
IL68769A
(en)
|
1983-05-23 |
1986-02-28 |
Hadassah Med Org |
Pharmaceutical compositions containing insulin for oral administration
|
|
CA1247547A
(en)
|
1983-06-22 |
1988-12-28 |
Paul Hadvary |
Leucine derivatives
|
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
|
US4722810A
(en)
|
1984-08-16 |
1988-02-02 |
E. R. Squibb & Sons, Inc. |
Enkephalinase inhibitors
|
|
US4654362A
(en)
|
1983-12-05 |
1987-03-31 |
Janssen Pharmaceutica, N.V. |
Derivatives of 2,2'-iminobisethanol
|
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
|
DK520784A
(da)
|
1984-01-21 |
1985-07-22 |
Hoechst Ag |
Cycliske polypeptider, deres fremstilling og anvendelse
|
|
GB8406906D0
(en)
|
1984-03-16 |
1984-04-18 |
Akzo Nv |
Benzo-thiazole and benzothiophene derivatives
|
|
US4849405A
(en)
|
1984-05-09 |
1989-07-18 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
|
EP0179904A1
(en)
|
1984-05-09 |
1986-05-07 |
Medaphore Inc. |
Oral insulin and a method of making the same
|
|
US4963526A
(en)
|
1984-05-09 |
1990-10-16 |
Synthetic Blood Corporation |
Oral insulin and a method of making the same
|
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
|
GR851085B
(pl)
|
1984-05-12 |
1985-11-25 |
Boehringer Mannheim Gmbh |
|
|
ZA853440B
(en)
|
1984-05-14 |
1986-12-30 |
Lilly Co Eli |
Indoline and 2-indolinone derivatives
|
|
DE3424685A1
(de)
|
1984-07-05 |
1986-02-06 |
Beiersdorf Ag, 2000 Hamburg |
Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
|
|
US4634765A
(en)
|
1984-12-18 |
1987-01-06 |
Merrell Dow Pharmaceuticals Inc. |
Homodisaccharide hypoglycemic agents
|
|
AR240698A1
(es)
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
JPS61218589A
(ja)
|
1985-03-26 |
1986-09-29 |
Eisai Co Ltd |
５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
|
|
DE3677316D1
(de)
|
1985-10-17 |
1991-03-07 |
Smith Kline French Lab |
4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate.
|
|
DE3543999A1
(de)
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
|
US5036048A
(en)
|
1986-03-07 |
1991-07-30 |
Schering Corporation |
Angiotensin II receptor blockers as antiglaucoma agents
|
|
HU215433B
(hu)
|
1986-04-29 |
2000-05-28 |
Pfizer Inc. |
Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US4749688A
(en)
|
1986-06-20 |
1988-06-07 |
Schering Corporation |
Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
|
|
US5138069A
(en)
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
|
ES2033922T3
(es)
|
1986-08-28 |
1993-04-01 |
Sandoz Ag |
Procedimiento para preparar nuevos derivados de xantina.
|
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
|
GB8630702D0
(en)
|
1986-12-23 |
1987-02-04 |
Wellcome Found |
Quinoline compound
|
|
CA1303037C
(en)
|
1987-02-02 |
1992-06-09 |
Smith Kline & French Laboratories Limited |
Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
|
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
|
US5041152A
(en)
|
1987-03-26 |
1991-08-20 |
Kabushiki Kaisha Toshiba |
Apparatus for bending tubular glass
|
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
|
NZ225447A
(en)
|
1987-07-20 |
1991-12-23 |
Merck & Co Inc |
Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
|
|
US6288095B1
(en)
|
1987-09-04 |
2001-09-11 |
Beecham Group P.L.C. |
Compounds
|
|
ATE186724T1
(de)
|
1987-09-04 |
1999-12-15 |
Beecham Group Plc |
Substituierte thiazolidindionderivate
|
|
US5192772A
(en)
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
|
US4880804A
(en)
|
1988-01-07 |
1989-11-14 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking benzimidazoles
|
|
CA1338238C
(en)
|
1988-01-07 |
1996-04-09 |
David John Carini |
Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
|
|
US5015651A
(en)
|
1988-01-07 |
1991-05-14 |
E. I. Du Pont De Nemours And Company |
Treatment of hypertension with 1,2,4-angiotensin II antagonists
|
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
|
US5142096A
(en)
|
1988-03-31 |
1992-08-25 |
Kyowa Hakko Kogyo Co., Ltd. |
2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds
|
|
EP0344383A1
(en)
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Novel alpha-Glucosidase inhibitors
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
US4916129A
(en)
|
1989-01-19 |
1990-04-10 |
E. I. Du Pont De Nemours And Company |
Combination β-blocking/angiotensin II blocking antihypertensives
|
|
JPH0710875B2
(ja)
|
1989-03-10 |
1995-02-08 |
雪印乳業株式会社 |
シアル酸類含有脱塩乳糖の製造方法
|
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
|
DE3928177A1
(de)
|
1989-04-08 |
1991-02-28 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
AU640137B2
(en)
|
1989-04-17 |
1993-08-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Novel arylpyridazines, their manufacture, use and medicaments containing them
|
|
EP0400835A1
(en)
|
1989-05-15 |
1990-12-05 |
Merck & Co. Inc. |
Substituted benzimidazoles as angiotensin II antagonists
|
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
|
IE64514B1
(en)
|
1989-05-23 |
1995-08-09 |
Zeneca Ltd |
Azaindenes
|
|
US5157026A
(en)
|
1989-05-30 |
1992-10-20 |
Merck & Co., Inc. |
Oxo-purines as angiotensin II antagonists
|
|
IL94390A
(en)
|
1989-05-30 |
1996-03-31 |
Merck & Co Inc |
The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
|
|
US5102880A
(en)
|
1989-05-30 |
1992-04-07 |
Merck & Co., Inc. |
Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists
|
|
US5064825A
(en)
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
|
EP0403158A3
(en)
|
1989-06-14 |
1991-12-18 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids
|
|
US5185351A
(en)
|
1989-06-14 |
1993-02-09 |
Smithkline Beecham Corporation |
Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
|
|
SG52330A1
(en)
|
1989-06-14 |
1998-09-28 |
Smithkline Beecham Corp |
Imidazolyl-alkenoic acids
|
|
WO1991000217A1
(en)
|
1989-06-29 |
1991-01-10 |
E.I. Du Pont De Nemours And Company |
Process for sterile addition of additives
|
|
KR950009860B1
(ko)
|
1989-06-30 |
1995-08-29 |
이. 아이. 듀퐁 드 네모아 앤드 캄파니 |
융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
|
|
KR0163595B1
(ko)
|
1989-06-30 |
1998-12-01 |
미리암디, 메코너헤이 |
치환된 이미다졸
|
|
CA2020073A1
(en)
|
1989-07-03 |
1991-01-04 |
Eric E. Allen |
Substituted quinazolinones as angiotensin ii antagonists
|
|
US5164407A
(en)
|
1989-07-03 |
1992-11-17 |
Merck & Co., Inc. |
Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
|
|
EP0407342A3
(en)
|
1989-07-06 |
1991-07-10 |
Ciba-Geigy Ag |
Pyrimidine derivatives
|
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
|
EP0409332A3
(en)
|
1989-07-19 |
1991-08-07 |
Merck & Co. Inc. |
Substituted triazoles as angiotensin ii antagonists
|
|
EP0412594B1
(en)
|
1989-07-28 |
1996-01-03 |
Merck & Co. Inc. |
Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
|
|
JPH0359757A
(ja)
|
1989-07-28 |
1991-03-14 |
Toshiba Corp |
神経回路網処理方式
|
|
ATE113281T1
(de)
|
1989-08-02 |
1994-11-15 |
Takeda Chemical Industries Ltd |
Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
|
|
ATE117294T1
(de)
|
1989-08-11 |
1995-02-15 |
Ici Plc |
Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
|
|
JP2862576B2
(ja)
|
1989-08-14 |
1999-03-03 |
日産自動車株式会社 |
カチオン電着塗料組成物
|
|
US5100897A
(en)
|
1989-08-28 |
1992-03-31 |
Merck & Co., Inc. |
Substituted pyrimidinones as angiotensin ii antagonists
|
|
EP0415886A3
(en)
|
1989-08-30 |
1991-10-23 |
Ciba-Geigy Ag |
Aza compounds
|
|
IE70593B1
(en)
|
1989-09-29 |
1996-12-11 |
Eisai Co Ltd |
Biphenylmethane derivative the use of it and pharmacological compositions containing same
|
|
EP0424317A3
(en)
|
1989-10-19 |
1991-09-25 |
Ciba-Geigy Ag |
Pyrimidines
|
|
IL95975A
(en)
|
1989-10-24 |
1997-06-10 |
Takeda Chemical Industries Ltd |
N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
|
|
AU640417B2
(en)
|
1989-10-25 |
1993-08-26 |
Smithkline Beecham Corporation |
Substituted 5-((tetrazolyl)alkenyl)imidazoles
|
|
IL96019A0
(en)
|
1989-10-31 |
1991-07-18 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
|
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
|
CA2028925A1
(en)
|
1989-11-06 |
1991-05-07 |
Gerald R. Girard |
Substituted n-(imidazolyl)alkyl alanine derivatives
|
|
CZ280006B6
(cs)
|
1989-11-13 |
1995-09-13 |
Pfizer Inc. |
Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu
|
|
US5391571A
(en)
|
1989-11-15 |
1995-02-21 |
American Home Products Corporation |
Cholesterol ester hydrolase inhibitors
|
|
PT95899A
(pt)
|
1989-11-17 |
1991-09-13 |
Glaxo Group Ltd |
Processo para a preparacao de derivados indole
|
|
IE903911A1
(en)
|
1989-11-20 |
1991-05-22 |
Ici Plc |
Diazine derivatives
|
|
US5073566A
(en)
|
1989-11-30 |
1991-12-17 |
Eli Lilly And Company |
Angiotensin ii antagonist 1,3-imidazoles and use thereas
|
|
GB8927277D0
(en)
|
1989-12-01 |
1990-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP0430709A3
(en)
|
1989-12-01 |
1992-02-12 |
Glaxo Group Limited |
Benzthiophen derivatives
|
|
EP0430300A3
(en)
|
1989-12-01 |
1992-03-25 |
Takeda Chemical Industries, Ltd. |
Xanthine derivatives, their production and use
|
|
US5104891A
(en)
|
1989-12-11 |
1992-04-14 |
G. D. Searle & Co. |
Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension
|
|
EP0433983B1
(en)
|
1989-12-20 |
1998-03-04 |
Texas Instruments Incorporated |
Copper etch process using halides
|
|
EP0434038A1
(en)
|
1989-12-22 |
1991-06-26 |
Takeda Chemical Industries, Ltd. |
Fused imidazole derivatives, their production and use
|
|
GB8929208D0
(en)
|
1989-12-27 |
1990-02-28 |
Almirall Lab |
New xanthine derivatives
|
|
EP0435827A3
(en)
|
1989-12-28 |
1991-11-13 |
Ciba-Geigy Ag |
Diaza compounds
|
|
CA2032289A1
(en)
|
1989-12-29 |
1991-06-30 |
Joseph A. Finkelstein |
Substituted 5-(alkyl) carboxamide imidazoles
|
|
CA2075639A1
(en)
|
1990-02-13 |
1991-08-14 |
William J. Greenlee |
Triazole angiotensin ii antagonists incorporating a substituted benzyl element
|
|
WO1991012001A1
(en)
|
1990-02-13 |
1991-08-22 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
|
DE69129998T2
(de)
|
1990-02-15 |
1998-12-24 |
Takeda Chemical Industries, Ltd., Osaka |
Pyrimidindionderivate, deren Herstellung und Verwendung
|
|
EP0443983B1
(de)
|
1990-02-19 |
1996-02-28 |
Ciba-Geigy Ag |
Acylverbindungen
|
|
CA2036618C
(en)
|
1990-02-22 |
2002-10-29 |
Akira Morimoto |
Fused thiophene derivatives, their production and use
|
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
|
DE4006693A1
(de)
|
1990-03-01 |
1991-09-05 |
Schering Ag |
Neue benzimidazolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
|
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
|
GB9005354D0
(en)
|
1990-03-09 |
1990-05-02 |
Glaxo Group Ltd |
Chemical compounds
|
|
US5287273A
(en)
|
1990-03-15 |
1994-02-15 |
Mount Sinai School Of Medicine |
Functional organ images
|
|
FR2659655B1
(fr)
|
1990-03-19 |
1992-07-24 |
Union Pharma Scient Appl |
Nouveaux derives d'oxypyrazole antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
|
US5155126A
(en)
|
1990-03-20 |
1992-10-13 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
|
|
TW201738B
(pl)
|
1990-03-20 |
1993-03-11 |
Sanofi Co |
|
|
US5270317A
(en)
|
1990-03-20 |
1993-12-14 |
Elf Sanofi |
N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
|
|
US5140037A
(en)
|
1990-03-20 |
1992-08-18 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
|
|
FR2681067B1
(fr)
|
1991-09-10 |
1993-12-17 |
Elf Sanofi |
Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5137906A
(en)
|
1990-03-20 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Treatment of central nervous system disorders with benzimidazole angiotensin-II receptor antagonists
|
|
US5173494A
(en)
|
1990-03-20 |
1992-12-22 |
E. I. Du Pont De Nemours And Company |
Specific inhibition of angiotensin-II binding to angiotensin-II receptor subtype-2
|
|
US5223516A
(en)
|
1990-03-22 |
1993-06-29 |
E. R. Squibb & Sons, Inc. |
3,3,3-trifluoro-2-mercaptomethyl-N-tetrazolyl substituted propanamides and method of using same
|
|
WO1991015209A1
(en)
|
1990-03-30 |
1991-10-17 |
Merck & Co., Inc. |
Substituted pyrimidines, pyrimidinones and pyridopyrimidines
|
|
JPH05505822A
(ja)
|
1990-03-30 |
1993-08-26 |
メルク・エンド・カムパニー・インコーポレーテツド |
ピラゾール類、イソキサゾール類及びイソチアゾール置換体
|
|
DE4010797A1
(de)
|
1990-04-04 |
1991-10-10 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
|
|
WO1991015206A1
(en)
|
1990-04-05 |
1991-10-17 |
E.I. Du Pont De Nemours And Company |
Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
|
|
JPH05507469A
(ja)
|
1990-04-13 |
1993-10-28 |
スミスクライン・ビーチャム・コーポレイション |
置換ベンズイミダゾール
|
|
GB2244054B
(en)
|
1990-04-19 |
1994-04-06 |
Ici Plc |
Pyridine derivatives
|
|
US5196444A
(en)
|
1990-04-27 |
1993-03-23 |
Takeda Chemical Industries, Ltd. |
1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
|
|
ES2149761T3
(es)
|
1990-04-25 |
2000-11-16 |
Nissan Chemical Ind Ltd |
Derivado de piridazinona.
|
|
US5703110A
(en)
|
1990-04-27 |
1997-12-30 |
Takeda Chemical Industries, Ltd. |
Benzimidazole derivatives, their production and use
|
|
US5642868A
(en)
|
1990-05-02 |
1997-07-01 |
The United States Of America As Represented By The Secretary Of The Navy |
Ceramic material
|
|
US5098920A
(en)
|
1990-05-04 |
1992-03-24 |
G. D. Searle & Co. |
1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
|
|
GB9010394D0
(en)
|
1990-05-09 |
1990-06-27 |
Ici Plc |
Heterocyclic compounds
|
|
MY105344A
(en)
|
1990-05-16 |
1994-09-30 |
Byk Gulden Lomberg Chemische Fabrik |
New sulphonyl compounds
|
|
EP0531382A1
(en)
|
1990-05-25 |
1993-03-17 |
G.D. Searle & Co. |
N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders
|
|
US5045540A
(en)
|
1990-05-25 |
1991-09-03 |
Warner-Lambert Co. |
Amino acid derivatives with angiotensin II antagonist properties
|
|
EP0461040A1
(fr)
|
1990-06-08 |
1991-12-11 |
Roussel Uclaf |
Dérivés de l'imidazole, leur procédé de préparation, les intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
|
|
US5504078A
(en)
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
|
WO1991019715A1
(en)
|
1990-06-15 |
1991-12-26 |
G.D. Searle & Co. |
1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
|
|
KR100196559B1
(ko)
|
1990-06-19 |
1999-06-15 |
기따사또 이찌로 |
안지오텐신ii 길항작용을 함유하는 피리딘 유도체
|
|
GB9013750D0
(en)
|
1990-06-20 |
1990-08-08 |
Pfizer Ltd |
Therapeutic agents
|
|
ATE146076T1
(de)
|
1990-06-22 |
1996-12-15 |
Du Pont |
Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten
|
|
NZ238688A
(en)
|
1990-06-28 |
1992-05-26 |
Smithkline Beecham Corp |
Substituted histidines: pharmaceutical compositions, preparation and uses thereof
|
|
IE912114A1
(en)
|
1990-07-02 |
1992-01-15 |
Union Pharma Scient Appl |
Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present
|
|
IL98319A
(en)
|
1990-07-05 |
1997-04-15 |
Roussel Uclaf |
Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
|
|
US5053329A
(en)
|
1990-07-05 |
1991-10-01 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
|
WO1992000968A1
(en)
|
1990-07-10 |
1992-01-23 |
Smithkline Beecham Corporation |
Oxamides
|
|
US5137902A
(en)
|
1990-07-13 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
4-alkylimidazole derivatives and anti-hypertensive use thereof
|
|
CA2044806A1
(en)
|
1990-07-18 |
1992-01-19 |
Roland Jaunin |
Purine derivatives
|
|
CA2047029A1
(en)
|
1990-07-19 |
1992-01-20 |
Shieh-Shung T. Chen |
Microbial transformation process for antihypertensive products
|
|
US5132216A
(en)
|
1990-07-19 |
1992-07-21 |
Merck & Co., Inc. |
Microbial transformation process for antihypertensive products
|
|
US5057522A
(en)
|
1990-07-19 |
1991-10-15 |
Merck & Co., Inc. |
Anti-hypersensitive N2-tetrazole-β-glucuronide analog
|
|
DE4023215A1
(de)
|
1990-07-21 |
1992-01-23 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
NZ239161A
(en)
|
1990-07-31 |
1994-01-26 |
Smithkline Beecham Corp |
Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
|
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
|
GB9017479D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Process
|
|
GB9017480D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Chemical process
|
|
GB9017482D0
(en)
|
1990-08-09 |
1990-09-26 |
Ici Plc |
Manufacturing process
|
|
EP0470543A1
(de)
|
1990-08-10 |
1992-02-12 |
Dr. Karl Thomae GmbH |
Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
|
|
AU8534291A
(en)
|
1990-08-10 |
1992-03-02 |
G.D. Searle & Co. |
Renal-selective angiotensin ii antagonists for treatment of hypertension
|
|
US5066586A
(en)
|
1990-08-20 |
1991-11-19 |
Merck & Co., Inc. |
Process for preparation of novel angiotensin II antagonists
|
|
US5089626A
(en)
|
1990-08-23 |
1992-02-18 |
Merck & Co., Inc. |
Process for preparing an angiotensin II antagonist
|
|
US5217985A
(en)
|
1990-08-28 |
1993-06-08 |
G. D. Searle & Co. |
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
|
|
WO1992004343A1
(fr)
|
1990-09-04 |
1992-03-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveau derive de tetrahydrobenzazole
|
|
IL99246A0
(en)
|
1990-09-10 |
1992-07-15 |
Abbott Lab |
Angiotensin ii receptor antagonists and pharmaceutical compositions containing them
|
|
IL99372A0
(en)
|
1990-09-10 |
1992-08-18 |
Ciba Geigy Ag |
Azacyclic compounds
|
|
EP0549712A1
(en)
|
1990-09-11 |
1993-07-07 |
Mectra Labs, Inc. |
Disposable lavage
|
|
US5140036A
(en)
|
1990-09-19 |
1992-08-18 |
G. D. Searle & Co. |
1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
|
US5210092A
(en)
|
1990-09-25 |
1993-05-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotensin ii antagonizing heterocyclic derivatives
|
|
US5091418A
(en)
|
1990-09-28 |
1992-02-25 |
Bristol-Myers Squibb Company |
Novel alpha-glucosidase inhibitor, pradimicin Q
|
|
US5242939A
(en)
|
1990-09-28 |
1993-09-07 |
Warner-Lambert Company |
Anilide derivatives with angiotensin ii antagonist properties
|
|
US5217877A
(en)
|
1990-09-28 |
1993-06-08 |
Bristol-Myers Squibb Company |
Process for the preparation of α-glucosidase inhibitor, pradimicin Q
|
|
EP0481614A1
(en)
|
1990-10-01 |
1992-04-22 |
Merck & Co. Inc. |
Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
|
|
US5126342A
(en)
|
1990-10-01 |
1992-06-30 |
Merck & Co., Inc. |
Imidazole angiotensin ii antagonists incorporating acidic functional groups
|
|
WO1992005784A1
(en)
|
1990-10-02 |
1992-04-16 |
Warner-Lambert Company |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists
|
|
US5260322A
(en)
|
1990-10-08 |
1993-11-09 |
Merck & Co., Inc. |
Angiotension II antagonists in the treatment of hyperuricemia
|
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
|
US5565473A
(en)
|
1990-10-12 |
1996-10-15 |
Merck Frosst Canada, Inc. |
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
|
|
CA2053148A1
(en)
|
1990-10-16 |
1992-04-17 |
Karnail Atwal |
Dihydropyrimidine derivatives
|
|
WO1992006963A1
(de)
|
1990-10-16 |
1992-04-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Arylpyridazinone
|
|
CA2053340C
(en)
|
1990-10-18 |
2002-04-02 |
Timothy P. Burkholder |
Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
|
AU9024591A
(en)
|
1990-10-25 |
1992-05-26 |
G.D. Searle & Co. |
Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders
|
|
AU636066B2
(en)
|
1990-10-30 |
1993-04-08 |
Takeda Chemical Industries Ltd. |
Thienoimidazole derivatives, their production and use
|
|
US5087634A
(en)
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
|
PH31175A
(en)
|
1990-10-31 |
1998-03-20 |
Squibb & Sons Inc |
Indole and benzimi-dazole-substituted imidazole and benzimidazole derivatives.
|
|
DE4036645A1
(de)
|
1990-11-16 |
1992-05-21 |
Hoechst Ag |
Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
|
|
GB9026006D0
(en)
|
1990-11-29 |
1991-01-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO1992009278A1
(en)
|
1990-11-30 |
1992-06-11 |
Smithkline Beecham Corporation |
Substituted 5-aryl imidazoles
|
|
CA2057089A1
(en)
|
1990-12-07 |
1992-06-08 |
Eric E. Allen |
Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
|
|
US5049565A
(en)
|
1990-12-07 |
1991-09-17 |
Merck & Co., Inc. |
Microbial transformation process for preparing anti-hypertensive products
|
|
GB9027197D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027055D0
(en)
|
1990-12-13 |
1991-02-06 |
Sandoz Ltd |
Organic compounds
|
|
AU657498B2
(en)
|
1990-12-14 |
1995-03-16 |
Novartis Ag |
Biphenylyl compounds
|
|
GB9027208D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027212D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027209D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027199D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027211D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027210D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027198D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9027200D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
EP0565634B1
(en)
|
1990-12-14 |
1999-03-17 |
Smithkline Beecham Corporation |
Angiotensin ii receptor blocking compositions
|
|
GB9027201D0
(en)
|
1990-12-14 |
1991-02-06 |
Smithkline Beecham Plc |
Medicaments
|
|
JPH04234389A
(ja)
|
1990-12-28 |
1992-08-24 |
Sapporo Breweries Ltd |
ナフチリジン誘導体及びそれを有効成分とする抗潰瘍剤
|
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
|
CA2058198A1
(en)
|
1991-01-04 |
1992-07-05 |
Adalbert Wagner |
Azole derivatives, process for their preparation, and their use
|
|
IE914573A1
(en)
|
1991-01-17 |
1992-07-29 |
Ici Plc |
Boron compounds
|
|
IE914572A1
(en)
|
1991-01-17 |
1992-07-29 |
Zeneca Ltd |
Chemical process
|
|
IE71647B1
(en)
|
1991-01-28 |
1997-02-26 |
Rhone Poulenc Rorer Ltd |
Benzamide derivatives
|
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
|
US5087702A
(en)
|
1991-01-30 |
1992-02-11 |
Merck & Co., Inc. |
Microbial transformation process for producing an antihypertensive product
|
|
US5124335A
(en)
|
1991-01-30 |
1992-06-23 |
Merck & Co., Inc. |
Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists
|
|
US5153347A
(en)
|
1991-01-31 |
1992-10-06 |
E. R. Squibb & Sons, Inc. |
Phosphonate, phosphinate derivatives useful as antihypertensive agents
|
|
AT395853B
(de)
|
1991-01-31 |
1993-03-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0498361A3
(en)
|
1991-02-06 |
1992-09-02 |
Schering Corporation |
Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor
|
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
IL100555A
(en)
|
1991-02-07 |
2000-08-31 |
Hoechst Marion Roussel Inc |
N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
|
|
MX9200299A
(es)
|
1991-02-07 |
1992-12-01 |
Roussel Uclaf |
Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
|
|
ATE156120T1
(de)
|
1991-02-07 |
1997-08-15 |
Roussel Uclaf |
Bizyklische stickstoffverbindungen, ihre herstellung, erhaltene zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
|
|
GB9102727D0
(en)
|
1991-02-08 |
1991-03-27 |
Ici Plc |
Pharmaceutical agent
|
|
GB9102803D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Pyridine compounds
|
|
GB9102804D0
(en)
|
1991-02-11 |
1991-03-27 |
Ici Plc |
Heterocyclic derivatives
|
|
IE920175A1
(en)
|
1991-02-11 |
1992-08-12 |
Zeneca Ltd |
Nitrogen heterocycles
|
|
IL100917A0
(en)
|
1991-02-16 |
1992-11-15 |
Fisons Plc |
Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
|
|
FR2672892B1
(fr)
|
1991-02-20 |
1994-01-14 |
Synthelabo |
Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.
|
|
CA2229000C
(en)
|
1991-02-21 |
2002-04-09 |
Sankyo Company, Limited |
1-biphenylimidazole derivatives, their preparation and their therapeutic use
|
|
US5104877A
(en)
|
1991-02-25 |
1992-04-14 |
Abbott Laboratories |
Psoriasis treatment
|
|
CA2061159A1
(en)
|
1991-02-26 |
1992-08-27 |
Michael A. Poss |
Imidazole and benzimidazole derivatives
|
|
US5187271A
(en)
|
1991-02-28 |
1993-02-16 |
G. D. Searle & Co. |
N-substituted (α-imidazolyl-toluyl) pyrrole compounds for treatment of circulatory disorders
|
|
FR2673427B1
(fr)
|
1991-03-01 |
1993-06-18 |
Sanofi Elf |
Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5202328A
(en)
|
1991-03-06 |
1993-04-13 |
Merck & Co., Inc. |
Substituted fused pyrimidinones
|
|
EP0503838A3
(en)
|
1991-03-08 |
1992-10-07 |
Merck & Co. Inc. |
Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists
|
|
EP0505098A1
(en)
|
1991-03-19 |
1992-09-23 |
Merck & Co. Inc. |
Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists
|
|
US5191086A
(en)
|
1991-03-19 |
1993-03-02 |
E.R. Squibb & Sons, Inc. |
Imidazole and benzimidazole derivatives
|
|
US5196537A
(en)
|
1991-03-21 |
1993-03-23 |
G. D. Searle & Co. |
5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
|
|
US5187179A
(en)
|
1991-03-22 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted imidazo [1,2-b][1,2,4]triazole
|
|
US5128327A
(en)
|
1991-03-25 |
1992-07-07 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle
|
|
WO1992016552A1
(en)
|
1991-03-25 |
1992-10-01 |
Glaxo Group Limited |
1-imidazolgemethyl benzofuran derivatives as inhibitors of angiotensin ii activity
|
|
IE73235B1
(en)
|
1991-03-25 |
1997-05-21 |
Akzo Nv |
4-aryl-thiazole or imidazole derivatives
|
|
US5177074A
(en)
|
1991-03-26 |
1993-01-05 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
US5164403A
(en)
|
1991-04-05 |
1992-11-17 |
G. D. Searle & Co. |
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
|
|
US5157040A
(en)
|
1991-04-05 |
1992-10-20 |
Merck & Co., Inc. |
Substituted quinolines as angiotensin ii antagonists
|
|
US5151435A
(en)
|
1991-04-08 |
1992-09-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating an indole or dihydroindole
|
|
US5155117A
(en)
|
1991-04-12 |
1992-10-13 |
G. D. Searle & Co. |
1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders
|
|
TW274551B
(pl)
|
1991-04-16 |
1996-04-21 |
Takeda Pharm Industry Co Ltd |
|
|
US5190942A
(en)
|
1991-04-22 |
1993-03-02 |
E. R. Squibb & Sons, Inc. |
Benzoxazole and related heterocyclic substituted imidazole and benzimidazole derivatives
|
|
US5252574A
(en)
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
|
US5449676A
(en)
|
1991-04-26 |
1995-09-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Pyridazines
|
|
CZ227093A3
(en)
|
1991-04-29 |
1994-03-16 |
Merck & Co Inc |
Mixture suitable for the preparation of tablets by direct moulding
|
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
|
US5191084A
(en)
|
1991-05-01 |
1993-03-02 |
American Home Products Corporation |
Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
|
|
US5198438A
(en)
|
1991-05-07 |
1993-03-30 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted thiophene or furan
|
|
US5162325A
(en)
|
1991-05-07 |
1992-11-10 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
|
JPH05112533A
(ja)
|
1991-05-08 |
1993-05-07 |
Upjohn Co:The |
イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
|
EP0586513A1
(en)
|
1991-05-10 |
1994-03-16 |
Merck & Co. Inc. |
Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
|
|
US5223501A
(en)
|
1991-05-10 |
1993-06-29 |
Merck & Co., Inc. |
Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
|
|
NZ242724A
(en)
|
1991-05-15 |
1994-09-27 |
Du Pont |
Synergistic composition comprising an angiotensin-ii receptor antagonist and a calcium channel blocker
|
|
GB9110532D0
(en)
|
1991-05-15 |
1991-07-03 |
Smithkline Beecham Corp |
Chemical compounds
|
|
GB9110625D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB9110636D0
(en)
|
1991-05-16 |
1991-07-03 |
Glaxo Group Ltd |
Chemical compounds
|
|
JPH06211845A
(ja)
|
1991-05-16 |
1994-08-02 |
Glaxo Group Ltd |
ベンゾフラン誘導体
|
|
KR920021542A
(ko)
|
1991-05-16 |
1992-12-18 |
배리 안토니 뉴샘 |
벤조푸란 유도체
|
|
US5292726A
(en)
|
1991-05-22 |
1994-03-08 |
Merck & Co., Inc. |
N,N-diacylpiperazines
|
|
FR2676734B1
(fr)
|
1991-05-23 |
1995-05-19 |
Roussel Uclaf |
Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
|
AU1625192A
(en)
|
1991-05-31 |
1992-12-03 |
Zeneca Limited |
Heterocyclic derivatives
|
|
US5175164A
(en)
|
1991-06-05 |
1992-12-29 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
|
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
|
FR2677984B1
(fr)
|
1991-06-21 |
1994-02-25 |
Elf Sanofi |
Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5210211A
(en)
|
1991-06-21 |
1993-05-11 |
Warner-Lambert Company |
4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
|
|
GB9113626D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic compounds
|
|
GB9113628D0
(en)
|
1991-06-25 |
1991-08-14 |
Ici Plc |
Heterocyclic derivatives
|
|
IL102183A
(en)
|
1991-06-27 |
1999-11-30 |
Takeda Chemical Industries Ltd |
Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
|
|
IL102365A0
(en)
|
1991-07-03 |
1993-01-14 |
Merck & Co Inc |
Substituted triazolinones,their preparation and pharmaceutical compositions containing them
|
|
FR2678618B1
(fr)
|
1991-07-05 |
1993-11-05 |
Upsa Laboratoires |
Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
|
|
DE4123341A1
(de)
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US5177097A
(en)
|
1991-07-24 |
1993-01-05 |
E. R. Squibb & Sons, Inc. |
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
|
|
GB9116039D0
(en)
|
1991-07-25 |
1991-09-11 |
Ucb Sa |
Substituted cyclopropylamino-1,3,5-triazines
|
|
AU2338992A
(en)
|
1991-07-26 |
1993-03-02 |
G.D. Searle & Co. |
Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders
|
|
IT1250749B
(it)
|
1991-08-02 |
1995-04-21 |
Luso Farmaco Inst |
Composti eterociclici ad attivita' a ii antagonista
|
|
WO1993003040A1
(fr)
|
1991-08-05 |
1993-02-18 |
Taisho Pharmaceutical Co., Ltd. |
Derive de thienopyrimidin-4-one
|
|
US5225401A
(en)
|
1991-08-12 |
1993-07-06 |
E. R. Squibb & Sons, Inc. |
Treatment of congestive heart failure
|
|
US5246944A
(en)
|
1991-08-13 |
1993-09-21 |
Merck & Co., Inc. |
Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
|
|
DK0528762T3
(da)
|
1991-08-15 |
1997-08-25 |
Ciba Geigy Ag |
N-acyl-N-heterocyclyl- eller naphthylalkyl-aminosyrer som angiotensin II antagonister
|
|
CZ36294A3
(en)
|
1991-08-19 |
1994-07-13 |
Du Pont |
Substituted imidazilonone derivatives and pharmaceutical preparations based thereon
|
|
CZ36394A3
(en)
|
1991-08-19 |
1994-07-13 |
Du Pont |
Substituted imidazilonone derivatives and pharmaceutical preparations based thereon
|
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
|
WO1993005025A1
(en)
|
1991-09-06 |
1993-03-18 |
Glaxo Group Limited |
C-linked pyrazole derivatives
|
|
EP0531874A1
(en)
|
1991-09-10 |
1993-03-17 |
Tanabe Seiyaku Co., Ltd. |
Imidazopyridine derivatives and process for preparation thereof
|
|
ATE146474T1
(de)
|
1991-09-10 |
1997-01-15 |
Tanabe Seiyaku Co |
Imidazoindolizinderivate mit angiotensin-ii hemmwirkung
|
|
TW300219B
(pl)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
|
US5256667A
(en)
|
1991-09-25 |
1993-10-26 |
Merck & Co., Inc. |
Quinazolinones and pyridopyrimidinones
|
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
|
CA2078758C
(en)
|
1991-09-27 |
2003-12-09 |
Alan M. Warshawsky |
2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
|
|
AU657793B2
(en)
|
1991-09-27 |
1995-03-23 |
Merrell Pharmaceuticals Inc. |
Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
|
ZA927211B
(en)
|
1991-09-27 |
1993-03-24 |
Merrell Dow Pharma |
Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE.
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
DE4132633A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Cyclisch substituierte imidazolyl-propensaeurederivate
|
|
DE4132631A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Imidazolyl-propensaeurederivate
|
|
DE4132632A1
(de)
|
1991-10-01 |
1993-04-08 |
Bayer Ag |
Substituierte imidazolyl-propensaeurederivate
|
|
AT398202B
(de)
|
1991-10-04 |
1994-10-25 |
Chem Pharm Forsch Gmbh |
Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5187159A
(en)
|
1991-10-07 |
1993-02-16 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
|
|
CA2079982A1
(en)
|
1991-10-07 |
1993-04-08 |
Stephen E. De Laszlo |
Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists
|
|
JP3245165B2
(ja)
|
1991-10-09 |
2002-01-07 |
シンテックス（ユー・エス・エイ）・インコーポレイテッド |
ピリドピリダジノンおよびピリダジンチオン化合物
|
|
GB9121463D0
(en)
|
1991-10-10 |
1991-11-27 |
Smithkline Beecham Corp |
Medicament
|
|
GB9121727D0
(en)
|
1991-10-14 |
1991-11-27 |
Ici Plc |
Heterocyclic compounds
|
|
US5149699A
(en)
|
1991-10-24 |
1992-09-22 |
American Home Products Corporation |
Substituted pyridopyrimidines useful as antgiotensin II antagonists
|
|
US5187168A
(en)
|
1991-10-24 |
1993-02-16 |
American Home Products Corporation |
Substituted quinazolines as angiotensin II antagonists
|
|
US5234936A
(en)
|
1991-10-24 |
1993-08-10 |
American Home Products Corporation |
Pyrimidocycloalkanes as a ii antagonists
|
|
JPH06107661A
(ja)
|
1991-10-24 |
1994-04-19 |
Upjohn Co:The |
イミダゾール誘導体およびこれを有効成分とする医薬組成物
|
|
US5336677A
(en)
|
1991-10-24 |
1994-08-09 |
American Home Products Corporation |
Substituted aminopyrimidines as antihypertensives
|
|
TW226375B
(pl)
|
1991-10-24 |
1994-07-11 |
American Home Prod |
|
|
FR2683819B1
(fr)
|
1991-10-28 |
1994-02-11 |
Synthelabo |
Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
|
|
JP3221894B2
(ja)
|
1991-10-31 |
2001-10-22 |
ダウ・コ−ニング・コ−ポレ−ション |
分岐オルガノポリシロキサンの製造方法
|
|
US5252753A
(en)
|
1991-11-01 |
1993-10-12 |
Ortho Pharmaceutical Corporation |
Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
|
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
|
US5182288A
(en)
|
1991-11-13 |
1993-01-26 |
Ortho Pharmaceutical Corporation |
Substituted n-biphenylyl lactams
|
|
EP0543263A3
(en)
|
1991-11-16 |
1993-08-25 |
Dr. Karl Thomae Gmbh |
Benziimidazoles, pharmaceuticals containing them and process for their preparation
|
|
US5130439A
(en)
|
1991-11-18 |
1992-07-14 |
Lo Young S |
Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
|
|
US5212177A
(en)
|
1991-12-16 |
1993-05-18 |
E. R. Squibb & Sons, Inc. |
Indole and benzimidazole-substituted dihydropyrimidine derivatives
|
|
EP0625162B1
(en)
|
1991-12-30 |
1998-05-13 |
Neurex Corporation |
Methods of producing analgesia and enhancing opiate analgesia
|
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
|
AU3588693A
(en)
|
1992-01-29 |
1993-09-01 |
Smithkline Beecham Corporation |
N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as TNF and PDE IV inhibitors
|
|
GB9204808D0
(en)
|
1992-03-04 |
1992-04-15 |
Rhone Poulenc Rorer Ltd |
Novel compositions of matter
|
|
US5208235A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Indole- and benzimidazole-substituted imidazole derivatives
|
|
US5208234A
(en)
|
1992-03-10 |
1993-05-04 |
E. R. Squibb & Sons, Inc. |
Substituted imidazole phosphonic and phosphinic acid derivatives
|
|
US5264437A
(en)
|
1992-03-20 |
1993-11-23 |
Syntex (U.S.A.) Inc. |
Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
|
|
FI944549L
(fi)
|
1992-04-02 |
1994-11-30 |
Smithkline Beecham Corp |
Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
|
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
|
EP0633771A4
(en)
|
1992-04-02 |
1995-02-22 |
Smithkline Beecham Corporation |
Compounds.
|
|
WO1993019747A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
US5212195A
(en)
|
1992-05-13 |
1993-05-18 |
Syntex (U.S.A.) Inc. |
Substituted indole antagonists derivatives which are angiotensin II
|
|
US5552397A
(en)
|
1992-05-18 |
1996-09-03 |
E. R. Squibb & Sons, Inc. |
Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
|
|
DK0640086T3
(da)
|
1992-05-15 |
1999-12-06 |
Merrell Pharma Inc |
Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
|
|
RU2124503C1
(ru)
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
|
CA2114114C
(en)
|
1992-06-15 |
2005-05-03 |
Nigel Robert Arnold Beeley |
Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
|
|
US5210204A
(en)
|
1992-06-16 |
1993-05-11 |
Warner-Lambert Company |
Biphenyl oxadiazoles and thiadiazoles as angiothesin II antagonists
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
４−アミノキナゾリン誘導体およびそれを含有する医薬品
|
|
IL106517A0
(en)
|
1992-07-28 |
1994-08-26 |
Rhone Poulenc Rorer Ltd |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
|
|
US5185340A
(en)
|
1992-08-04 |
1993-02-09 |
American Home Products Corporation |
Pyrimidinyl arylalkyl ethers with antihypertensive activity
|
|
US5741803A
(en)
|
1992-09-05 |
1998-04-21 |
Smithkline Beecham Plc |
Substituted thiazolidinedionle derivatives
|
|
ES2132254T3
(es)
|
1992-09-14 |
1999-08-16 |
Forssmann Wolf Georg Prof Dr |
Nueva utilizacion de inhibidores de la fosfodiesterasa iv.
|
|
US5349056A
(en)
|
1992-10-09 |
1994-09-20 |
Regeneron Pharmaceuticals |
Modified ciliary neurotrophic factors
|
|
US6472178B1
(en)
|
1998-02-27 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
|
|
US5504080A
(en)
|
1992-10-28 |
1996-04-02 |
Bristol-Myers Squibb Co. |
Benzo-fused lactams
|
|
DK0672031T3
(da)
|
1992-12-02 |
2003-06-10 |
Pfizer |
Catecholdiethere som selektive PDE IV-inhibitorer
|
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
|
TW263495B
(pl)
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
|
JP3339730B2
(ja)
|
1992-12-24 |
2002-10-28 |
忠弘 大見 |
半導体装置
|
|
US5594016A
(en)
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
|
US5451677A
(en)
|
1993-02-09 |
1995-09-19 |
Merck & Co., Inc. |
Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
|
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
|
US5459151A
(en)
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
|
GB9309324D0
(en)
|
1993-05-06 |
1993-06-16 |
Bayer Ag |
Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
|
|
US6191105B1
(en)
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
GB9311282D0
(en)
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
|
JPH0710875A
(ja)
|
1993-06-21 |
1995-01-13 |
Green Cross Corp:The |
選択的ホスホジエステラーゼｉｖ阻害剤
|
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
|
CZ290266B6
(cs)
|
1993-07-02 |
2002-06-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
|
|
CN1048015C
(zh)
|
1993-07-06 |
2000-01-05 |
美国辉瑞有限公司 |
双环四氢吡唑并吡啶类化合物
|
|
US5362727A
(en)
|
1993-07-26 |
1994-11-08 |
Bristol-Myers Squibb |
Substituted azepino[2,1-a]isoquinoline compounds
|
|
ZA945609B
(en)
|
1993-07-28 |
1995-05-12 |
Rhone Poulenc Rorer Ltd |
[Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
|
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
|
JPH09501420A
(ja)
|
1993-07-30 |
1997-02-10 |
スミスクライン・ビーチャム・コーポレイション |
３−シアノ−３−（３，４−二置換）フェニルシクロヘキシル−１−カルボキシレート類
|
|
WO1995005386A1
(en)
|
1993-08-19 |
1995-02-23 |
Smithkline Beecham Corporation |
Phenethylamine compounds
|
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
|
WO1995009623A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Anti-allergic, anti-inflammatory compounds, compositions and uses
|
|
JPH09503503A
(ja)
|
1993-10-01 |
1997-04-08 |
スミスクライン・ビーチャム・コーポレイション |
化合物、組成物ならびにアレルギーおよび炎症の治療
|
|
EP0727990B1
(en)
|
1993-10-01 |
2001-06-13 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation
|
|
WO1995009836A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Cyanocyclohexane compounds, compositions, and uses thereof
|
|
GB9322828D0
(en)
|
1993-11-05 |
1993-12-22 |
Sandoz Ltd |
Organic compounds
|
|
US5525723A
(en)
|
1993-11-18 |
1996-06-11 |
Bristol-Myers Squibb Co. |
Compounds containing a fused multiple ring lactam
|
|
JP2818820B2
(ja)
|
1993-11-26 |
1998-10-30 |
ファイザー・インク． |
抗炎症剤としての３−アリール−２−イソオキサゾリン類
|
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
|
CZ283564B6
(cs)
|
1993-11-26 |
1998-05-13 |
Pfizer Inc. |
3-Aryl-2-isoxazolin-5-hydroxamové kyseliny a farmaceutické prostředky na jejich bázi
|
|
FR2714057B1
(fr)
|
1993-12-17 |
1996-03-08 |
Sanofi Elf |
Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant.
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
EP0738268B1
(en)
|
1993-12-22 |
2004-03-03 |
Celltech R&D Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
|
US5508300A
(en)
|
1994-01-14 |
1996-04-16 |
Pfizer Inc. |
Dihydro pyrazolopyrroles, compositions and use
|
|
JP2928079B2
(ja)
|
1994-02-14 |
1999-07-28 |
永信薬品工業股▲ふん▼有限公司 |
１−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
|
|
ES2130597T3
(es)
|
1994-02-17 |
1999-07-01 |
American Home Prod |
Derivados de bifenilo sustituido como inhibidores de la fosfodiesterasa.
|
|
CA2143143A1
(en)
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
|
GB9404706D0
(en)
|
1994-03-11 |
1994-04-27 |
Smithkline Beecham Corp |
Compounds
|
|
WO1995027692A1
(en)
|
1994-04-08 |
1995-10-19 |
Smithkline Beecham Corporation |
Subtituted biphenyl tnf inhibitors
|
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
|
DE69532238T2
(de)
|
1994-04-21 |
2004-10-21 |
Schering Ag |
Pde iv-inhibitoren zur behandlung der multiplen sklerose
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
HRP950288A2
(en)
|
1994-05-31 |
1997-08-31 |
Bayer Ag |
Oxalylamino-benzofuran- and benzothienyl-derivatives
|
|
ES2127966T3
(es)
|
1994-05-31 |
1999-05-01 |
Bayer Ag |
Derivados de amino-benzofurilo y -benzotienilo.
|
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
|
GB9412383D0
(en)
|
1994-06-21 |
1994-08-10 |
Celltech Ltd |
Chemical compound
|
|
JP3056788B2
(ja)
|
1994-06-24 |
2000-06-26 |
ユーロ−セルティーク，エス．エイ． |
ホスホジエステラーゼｉｖの阻害化合物および阻害方法
|
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
|
ES2152414T3
(es)
|
1994-07-22 |
2001-02-01 |
Byk Gulden Lomberg Chem Fab |
Dihidrobenzofuranos.
|
|
US5612359A
(en)
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
|
US5491134A
(en)
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
|
AU699489B2
(en)
|
1994-10-12 |
1998-12-03 |
Euro-Celtique S.A. |
Novel benzoxazoles
|
|
WO1996014307A1
(en)
|
1994-11-07 |
1996-05-17 |
Pfizer Inc. |
Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
US5902726A
(en)
|
1994-12-23 |
1999-05-11 |
Glaxo Wellcome Inc. |
Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
|
|
US5843866A
(en)
|
1994-12-30 |
1998-12-01 |
Hampshire Chemical Corp. |
Pesticidal compositions comprising solutions of polyurea and/or polyurethane
|
|
US5559208A
(en)
|
1995-01-31 |
1996-09-24 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552524A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
JPH11501297A
(ja)
|
1995-01-31 |
1999-02-02 |
イーライ・リリー・アンド・カンパニー |
抗肥満症タンパク質
|
|
EP0725079A1
(en)
|
1995-01-31 |
1996-08-07 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5521283A
(en)
|
1995-01-31 |
1996-05-28 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5554727A
(en)
|
1995-01-31 |
1996-09-10 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5605886A
(en)
|
1995-01-31 |
1997-02-25 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552523A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5552522A
(en)
|
1995-01-31 |
1996-09-03 |
Eli Lilly And Company |
Anti-obesity proteins
|
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
US20020006964A1
(en)
|
1995-05-16 |
2002-01-17 |
Young James W. |
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds
|
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
|
TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
|
DE69627153T2
(de)
|
1995-06-27 |
2003-12-04 |
Elan Pharmaceuticals, Inc.(N.D.Ges.D.Staates Delaware) |
Zusammensetzungen zur erzielung von analgesie und zur hemmung der progression neuropathischer schmerzerkrankungen
|
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
|
EP0788353A1
(en)
|
1995-09-18 |
1997-08-13 |
Ligand Pharmaceuticals, Inc. |
Ppar gamma antagonists for treating obesity
|
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
|
ATE289994T1
(de)
|
1995-11-24 |
2005-03-15 |
Glaxosmithkline Spa |
Chinolin-derivate
|
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
|
US6482927B1
(en)
|
1995-11-27 |
2002-11-19 |
Millennium Pharmaceuticals, Inc. |
Chimeric proteins comprising the extracellular domain of murine Ob receptor
|
|
WO1997020822A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Quinazolin-2,4-diazirines as npy receptor antagonist
|
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
|
AU7692996A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Receptor antagonists
|
|
WO1997020821A1
(en)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Heteroaryl derivatives
|
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
|
JP2000502086A
(ja)
|
1995-12-13 |
2000-02-22 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
核レセプターのリガンドおよびリガンド結合ドメイン
|
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
|
JP2002503202A
(ja)
|
1996-02-02 |
2002-01-29 |
メルク エンド カンパニー インコーポレーテッド |
抗糖尿病薬
|
|
CA2244831A1
(en)
|
1996-02-02 |
1997-08-07 |
John T. Olson |
Method of treating diabetes and related disease states
|
|
CA2245524A1
(en)
|
1996-02-02 |
1997-08-07 |
Wei Han |
Antidiabetic agents
|
|
ATE236137T1
(de)
|
1996-02-02 |
2003-04-15 |
Merck & Co Inc |
Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit
|
|
US6017919A
(en)
|
1996-02-06 |
2000-01-25 |
Japan Tobacco Inc. |
Compounds and pharmaceutical use thereof
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
JP2000511903A
(ja)
|
1996-06-07 |
2000-09-12 |
メルク エンド カンパニー インコーポレーテッド |
糖尿病および肥満の治療のための選択性β▲下３▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド
|
|
EP0930882A2
(en)
|
1996-08-02 |
1999-07-28 |
Institut Pasteur De Lille |
Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
|
|
WO1998011090A2
(en)
|
1996-09-16 |
1998-03-19 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
IT1288388B1
(it)
|
1996-11-19 |
1998-09-22 |
Angeletti P Ist Richerche Bio |
Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
|
|
DE69729315T2
(de)
|
1996-12-16 |
2005-06-23 |
Banyu Pharmaceutical Co., Ltd. |
Aminopyrazolderivate
|
|
JPH10237049A
(ja)
|
1996-12-24 |
1998-09-08 |
Nippon Chemiphar Co Ltd |
ベンズイソキサゾ−ル誘導体
|
|
JP4798814B2
(ja)
|
1997-01-07 |
2011-10-19 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
食物摂取低減用のエキセンジンおよびそのアゴニストの使用
|
|
CA2278307A1
(en)
|
1997-01-21 |
1998-07-23 |
Siegfried Benjamin Christensen Iv |
Novel cannabinoid receptor modulators
|
|
IL131130A0
(en)
|
1997-01-28 |
2001-01-28 |
Merck & Co Inc |
Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
|
|
AU5932098A
(en)
|
1997-02-04 |
1998-08-25 |
E.I. Du Pont De Nemours And Company |
Fungicidal carboxamides
|
|
US6589750B2
(en)
|
1997-02-20 |
2003-07-08 |
Institut Pasteur |
Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
|
|
CA2470183C
(en)
|
1997-02-21 |
2008-01-29 |
Bayer Aktiengesellschaft |
Intermediates for preparing arylsulphonamides and analogues
|
|
US6153632A
(en)
|
1997-02-24 |
2000-11-28 |
Rieveley; Robert B. |
Method and composition for the treatment of diabetes
|
|
EP0979228A4
(en)
|
1997-03-18 |
2000-05-03 |
Smithkline Beecham Corp |
CANNABINOID RECEPTOR AGONISTS
|
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
|
JP4228398B2
(ja)
|
1997-04-23 |
2009-02-25 |
萬有製薬株式会社 |
神経ペプチドｙ受容体拮抗剤
|
|
AU735760B2
(en)
|
1997-04-24 |
2001-07-12 |
Merck Sharp & Dohme Limited |
Use of a NK-1 receptor antagonist and an SSRI for treating obesity
|
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
|
SE9702457D0
(sv)
|
1997-06-26 |
1997-06-26 |
Pharmacia & Upjohn Ab |
Screening
|
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
|
WO1999014239A1
(de)
|
1997-09-12 |
1999-03-25 |
Wolf Georg Forssmann |
Zusammensetzung zur therapie von diabetes mellitus und fettsucht
|
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
EP1124807A1
(en)
|
1997-10-27 |
2001-08-22 |
Dr. Reddy's Research Foundation |
Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
CA2309356C
(en)
|
1997-11-14 |
2010-09-21 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
|
WO1999038850A1
(en)
|
1998-01-29 |
1999-08-05 |
Dr. Reddy's Research Foundation |
Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
EP1052994A2
(en)
|
1998-02-02 |
2000-11-22 |
Trustees Of Tufts College |
Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
|
|
EP1062222A1
(en)
|
1998-03-09 |
2000-12-27 |
Fondatech Benelux N.V. |
Serine peptidase modulators
|
|
CA2328607A1
(en)
|
1998-04-02 |
1999-10-14 |
Kun Liu |
Antidiabetic agents
|
|
EP1068207A1
(en)
|
1998-04-02 |
2001-01-17 |
Neurogen Corporation |
AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
|
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
|
TR200100137T2
(tr)
|
1998-04-29 |
2001-05-21 |
Ortho-Mcneil Pharmaceutical, Inc. |
Obesitenin ve başka bozuklukların tedavisinde yararlı nöropeptit Y Y5 reseptörü için ligandlar olarak N-ikameli aminotetralinler.
|
|
AU3979199A
(en)
|
1998-05-12 |
1999-11-29 |
American Home Products Corporation |
11-aryl-benzo{b}naphtho{2,3-d}furans and 11-aryl-benzo{b}naphtho{2,3-d}thiophenes useful in the treatment of insulin resistance and hyperglycemia
|
|
EP1077968A1
(en)
|
1998-05-12 |
2001-02-28 |
American Home Products Corporation |
Naphtho[2,3-b]heteroar-4-yl derivatives
|
|
WO1999058518A2
(en)
|
1998-05-12 |
1999-11-18 |
American Home Products Corporation |
Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
|
|
HRP20000767A2
(en)
|
1998-05-12 |
2001-10-31 |
American Home Prod |
Benzothiophenes, benzofurans and indoles useful in the treatment of insulin resistance and hyperglycemia
|
|
JP2002507543A
(ja)
|
1998-05-27 |
2002-03-12 |
ドクター・レディーズ・リサーチ・ファウンデーション |
二環系化合物、その製造方法およびそれらを含有する薬学的組成物
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
|
WO2000015790A2
(en)
|
1998-09-10 |
2000-03-23 |
Millennium Pharmaceuticals, Inc. |
Leptin induced genes
|
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
|
DE19844547C2
(de)
|
1998-09-29 |
2002-11-07 |
Aventis Pharma Gmbh |
Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE69942009D1
(de)
|
1998-10-15 |
2010-03-25 |
Imp Innovations Ltd |
Verbindungen für die behandlung von gewichtsverlust
|
|
WO2000023445A1
(en)
|
1998-10-21 |
2000-04-27 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1123269A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
AU6190199A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
EP1129089B1
(en)
|
1998-11-10 |
2005-12-28 |
Merck & Co., Inc. |
Spiro-indolines as y5 receptor antagonists
|
|
ES2161594B1
(es)
|
1998-12-17 |
2003-04-01 |
Servier Lab |
Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
|
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
|
SK12992001A3
(sk)
|
1999-03-19 |
2002-03-05 |
Knoll Gmbh |
Použitie zlúčeniny a farmaceutická kompozícia ju obsahujúca
|
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
|
FR2792314B1
(fr)
|
1999-04-15 |
2001-06-01 |
Adir |
Nouveaux composes aminotriazoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
JP2002543067A
(ja)
|
1999-04-22 |
2002-12-17 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的なｎｐｙ（ｙ５）のアンタゴニスト
|
|
US6218408B1
(en)
|
1999-06-30 |
2001-04-17 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
EP1177172A1
(en)
|
1999-05-05 |
2002-02-06 |
Ortho-McNeil Pharmaceutical, Inc. |
3a,4,5,9b-TETRAHYDRO-1H-BENZ e]INDOL-2-YL AMINE-DERIVED NEUROPEPTIDE Y RECEPTORS LIGANDS USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
|
|
EP1177188B1
(en)
|
1999-05-12 |
2005-10-12 |
Ortho-McNeil Pharmaceutical, Inc. |
Pyrazole carboxamides useful for the treatment of obesity and other disorders
|
|
WO2001024786A1
(en)
|
1999-05-13 |
2001-04-12 |
Shionogi & Co., Ltd. |
Preventive or therapeutic drugs for diabetes
|
|
WO2000074679A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
GB9913782D0
(en)
|
1999-06-14 |
1999-08-11 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO2000077001A1
(en)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Substituted heterocycle fused gamma-carbolines
|
|
US6207699B1
(en)
|
1999-06-18 |
2001-03-27 |
Richard Brian Rothman |
Pharmaceutical combinations for treating obesity and food craving
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
ATE414529T1
(de)
|
1999-06-23 |
2008-12-15 |
Pasteur Institut |
Zusammensetzungen zur behandlung von beeinträchtigten zwischenmenschlischen störungen und verhaltenstörungen
|
|
AU773892B2
(en)
|
1999-06-30 |
2004-06-10 |
H. Lundbeck A/S |
Selective NPY (Y5) antagonists
|
|
WO2001000579A1
(en)
|
1999-06-30 |
2001-01-04 |
Tularik Inc. |
COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY
|
|
WO2001007409A1
(en)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Carbazole derivatives and their use as neuropeptide y5 receptor ligands
|
|
HUP0202143A3
(en)
|
1999-07-28 |
2003-12-29 |
Ortho Mcneil Pharm Inc |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use
|
|
EP1078632A1
(en)
|
1999-08-16 |
2001-02-28 |
Sanofi-Synthelabo |
Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
|
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
|
WO2001013917A1
(en)
|
1999-08-26 |
2001-03-01 |
Bristol-Myers Squibb Company |
Npy antagonists: spiroisoquinolinone derivatives
|
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
|
WO2001021169A1
(en)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Mch antagonists
|
|
YU23602A
(sh)
|
1999-09-30 |
2004-09-03 |
Neurogen Corporation |
Amino supstituisani pirazolo /1,5/a/-1,5-pirimidini i pirazolo /1,5-a/-1,3,5-triazini
|
|
AU7738000A
(en)
|
1999-09-30 |
2001-04-30 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
PL354675A1
(pl)
|
1999-09-30 |
2004-02-09 |
Neurogen Corporation |
Alkileno-diamino podstawione pirazolo[1,5-a]-1,5-pirymidyny i pirazolo[1,5-a]-1,3,5-triazyny
|
|
AU7802700A
(en)
|
1999-10-06 |
2001-05-10 |
Melacure Therapeutics Ab |
Guanidine derivatives and their use in the production of a medicament for blocking xanthine oxidase/dehydrogenase
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
DE19949319A1
(de)
|
1999-10-13 |
2001-06-13 |
Ruetgers Vft Ag |
Verfahren zur Herstellung von Arylalkylethern
|
|
SK4732002A3
(en)
|
1999-10-13 |
2002-12-03 |
Pfizer Prod Inc |
Biaryl ether derivatives useful as monoamine reuptake inhibitors
|
|
EE200200235A
(et)
|
1999-11-05 |
2003-06-16 |
Aventis Pharma Deutschland Gmbh |
Indeno-, nafto- ja bensotsükloheptadihüdrotiasooli derivaadid, nende valmistamine ja kasutamine anorektiliste ravimitena
|
|
DE60022386T2
(de)
|
1999-12-16 |
2006-06-22 |
Schering Corp. |
Substituierte imidazole als neuropeptide y y5 rezeptor antagonisten
|
|
JP3226269B2
(ja)
|
1999-12-20 |
2001-11-05 |
株式会社ノダ |
暖房床材の製造方法およびその施工方法ならびに暖房床構造
|
|
FR2802817B1
(fr)
|
1999-12-23 |
2002-10-11 |
Centre Nat Rech Scient |
Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
|
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
AU2001214778A1
(en)
|
2000-01-26 |
2001-08-07 |
Warner Lambert Company |
Method for preventing or treating postoperative ileus
|
|
AU2001228325A1
(en)
|
2000-02-01 |
2001-08-14 |
Novo-Nordisk A/S |
Use of compounds for the regulation of food intake
|
|
JP2004502642A
(ja)
|
2000-02-11 |
2004-01-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
|
|
JP2001226269A
(ja)
|
2000-02-18 |
2001-08-21 |
Takeda Chem Ind Ltd |
メラニン凝集ホルモン拮抗剤
|
|
GB0004003D0
(en)
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
|
EP1264826B1
(en)
|
2000-02-22 |
2005-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Novel imidazoline compounds
|
|
YU56302A
(sh)
|
2000-02-23 |
2005-11-28 |
Aventis Pharma Deutschland Gmbh. |
Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva
|
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
|
NZ520981A
(en)
|
2000-02-26 |
2004-08-27 |
Aventis Pharma Gmbh |
8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
|
|
WO2001064212A1
(en)
|
2000-03-01 |
2001-09-07 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
ES2234840T3
(es)
|
2000-03-14 |
2005-07-01 |
Actelion Pharmaceuticals Ltd. |
Derivados de 1,2,3,4- tetrahidroisoquinolina.
|
|
JP2003527444A
(ja)
|
2000-03-23 |
2003-09-16 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体アゴニストとして作用するスピロピペリジン誘導体
|
|
CA2403686C
(en)
|
2000-03-23 |
2010-01-26 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin receptor agonists
|
|
PL208098B1
(pl)
|
2000-03-23 |
2011-03-31 |
Solvay Pharm Bv |
Pochodne 4,5-dihydro-1H-pirazolu, kompozycja farmaceutyczna, sposób wytwarzania związków oraz ich zastosowanie
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
EP1142886A1
(en)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinnin, a process for its production and its use as a pharmaceutical
|
|
JP2004501076A
(ja)
|
2000-04-17 |
2004-01-15 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、それらの製造及び使用
|
|
CN1630532A
(zh)
|
2000-04-19 |
2005-06-22 |
约翰斯霍普金斯大学 |
预防和治疗胃肠疾病的方法
|
|
PT1285651E
(pt)
|
2000-04-28 |
2010-10-21 |
Takeda Pharmaceutical |
Antagonistas da hormona concentradora da melanina
|
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
|
WO2001085173A1
(en)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Alkylamine derivatives of dihydropyridine npy antagonists
|
|
JP2004507456A
(ja)
|
2000-05-11 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
|
|
EP1283199A4
(en)
|
2000-05-16 |
2003-12-17 |
Takeda Chemical Industries Ltd |
MELANINE CONCENTRATING HORMONE ANTAGONISTS
|
|
EP1286697A2
(en)
|
2000-05-17 |
2003-03-05 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
EP1289526A4
(en)
|
2000-05-30 |
2005-03-16 |
Merck & Co Inc |
MELANOCORTIN RECEPTOR AGONISTS
|
|
AU6231801A
(en)
|
2000-06-09 |
2001-12-17 |
Aventis Pharma Gmbh |
Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
|
|
KR100604742B1
(ko)
|
2000-06-15 |
2006-07-26 |
쉐링 코포레이션 |
트롬빈 수용체 길항제
|
|
EP1289955B1
(en)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
|
EP1299362A4
(en)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
|
WO2002004433A2
(en)
|
2000-07-06 |
2002-01-17 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
|
HUP0301329A2
(hu)
|
2000-07-13 |
2003-08-28 |
Eli Lilly And Co. |
Béta3 Adrenergiás agonisták, valamint ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás e vegyületek előállítására
|
|
CN1443198A
(zh)
|
2000-07-24 |
2003-09-17 |
阿达纳生物科学有限公司 |
Ghrelin拮抗剂
|
|
WO2002010169A1
(en)
|
2000-07-31 |
2002-02-07 |
F. Hoffmann-La Roche Ag |
Piperazine derivatives
|
|
US6768024B1
(en)
|
2000-08-04 |
2004-07-27 |
Lion Bioscience Ag |
Triamine derivative melanocortin receptor ligands and methods of using same
|
|
GB0019359D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
|
JP4790969B2
(ja)
|
2000-08-11 |
2011-10-12 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
US6680340B2
(en)
|
2000-08-21 |
2004-01-20 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
|
EP1320364A1
(en)
|
2000-08-21 |
2003-06-25 |
Gliatech, Inc. |
The use of histamine h3-receptor inverse agonists for the control of appetite and treatment of obesity
|
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
|
JP2004506687A
(ja)
|
2000-08-23 |
2004-03-04 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン受容体作働薬としての置換ピペリジン類
|
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
|
MXPA03002263A
(es)
|
2000-09-14 |
2003-06-24 |
Schering Corp |
Antagonistas de receptor de neuropeptido y y5 de urea sustituidos.
|
|
AU2001292480A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel pyridazine compounds for the treatment of diabetes
|
|
AU2001292518A1
(en)
|
2000-09-26 |
2002-04-08 |
Biovitrum Ab |
Novel compounds
|
|
JP2002114768A
(ja)
|
2000-10-11 |
2002-04-16 |
Japan Tobacco Inc |
２−（２，５−ジハロゲン−３，４−ジヒドロキシフェニル）アゾール化合物及びそれを含有してなる医薬組成物
|
|
CZ20031029A3
(cs)
|
2000-10-13 |
2003-09-17 |
Eli Lilly And Company |
Substituované dipeptidy jako sekretagogy růstového hormonu
|
|
WO2002044152A1
(en)
|
2000-10-16 |
2002-06-06 |
F. Hoffmann-La Roche Ag |
Indoline derivatives and their use as 5-ht2 receptor ligands
|
|
WO2002032897A1
(en)
|
2000-10-20 |
2002-04-25 |
Pfizer Products Inc. |
Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
|
|
WO2002036596A2
(en)
|
2000-11-03 |
2002-05-10 |
Wyeth |
CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
|
|
DE60120748T2
(de)
|
2000-11-10 |
2007-05-16 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindolderivate als beta-3-agonisten
|
|
JP4204315B2
(ja)
|
2000-11-20 |
2009-01-07 |
ビオヴィトルム・アクチボラゲット（プブリクト） |
セロトニン５−ｈｔ２レセプターのアンタゴニストとしてのピペラジニルピラジン化合物
|
|
AU2426602A
(en)
|
2000-11-20 |
2002-05-27 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
|
EP1353918B1
(en)
|
2000-11-28 |
2005-01-12 |
Smithkline Beecham Plc |
Morpholine derivatives as antagonists of orexin receptors
|
|
EP1341774B1
(en)
|
2000-12-06 |
2006-02-01 |
F. Hoffmann-La Roche Ag |
Fused heteroaromatic glucokinase activators
|
|
JP2004520299A
(ja)
|
2000-12-12 |
2004-07-08 |
ニューロジェン・コーポレーション |
スピロ［イソベンゾフラン−１，４’−ピペリジン］−３−オン類及び３ｈ−スピロイソベンゾフラン−１，４’−ピペリジン類
|
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
|
EP2123293A3
(en)
|
2000-12-14 |
2010-09-08 |
Amylin Pharmaceuticals, Inc. |
Peptide YY and petide YY agonists for treatment of metabolic disorders
|
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
|
SG138463A1
(en)
|
2000-12-21 |
2008-01-28 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
|
HUP0302582A2
(hu)
|
2000-12-22 |
2003-12-29 |
Schering Corp. |
Piperidin MCH antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk elhízás kezelésére
|
|
DE60018085T2
(de)
|
2000-12-22 |
2005-07-07 |
Institut Pasteur |
Prozess zum Screening von Molekülen, die spezifisch an die NEP-Bindungsstelle des QHNPR-pentapeptides binden
|
|
NZ526623A
(en)
|
2000-12-22 |
2004-11-26 |
Astrazeneca Ab |
Carbazole derivatives and their use as neuropeptide Y5 receptor ligands
|
|
BR0116605A
(pt)
|
2000-12-27 |
2003-09-30 |
Hoffmann La Roche |
Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono
|
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
|
JP2004523530A
(ja)
|
2001-01-23 |
2004-08-05 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニストとしてのピペラジンおよびピペリジン誘導体
|
|
CA2433025A1
(en)
|
2001-01-23 |
2002-08-01 |
Chaoyu Xie |
Substituted piperidines/piperazines as melanocortin receptor agonists
|
|
EP1358163A1
(en)
|
2001-01-23 |
2003-11-05 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
EP1385548B1
(en)
|
2001-01-26 |
2007-05-23 |
Schering Corporation |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
|
BR0206831A
(pt)
|
2001-02-02 |
2004-07-06 |
Takeda Chemical Industries Ltd |
Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto
|
|
EP1363914A1
(en)
|
2001-02-05 |
2003-11-26 |
Dr. Reddy's Laboratories Ltd. |
Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
|
|
CA2439152C
(en)
|
2001-02-28 |
2008-06-17 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
|
JP4316238B2
(ja)
|
2001-02-28 |
2009-08-19 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−４受容体作動薬としてのアシル化ピペリジン誘導体
|
|
ATE341327T1
(de)
|
2001-02-28 |
2006-10-15 |
Merck & Co Inc |
Acylierte piperidin-derivate als melanocortin-4- rezeptor-agonisten
|
|
GB0105772D0
(en)
|
2001-03-08 |
2001-04-25 |
Sterix Ltd |
Use
|
|
AU2002247367B2
(en)
|
2001-03-21 |
2005-10-27 |
Pharmacopeia Drug Discovery, Inc. |
Aryl and biaryl compounds having MCH modulatory activity
|
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
|
CZ2003698A3
(cs)
|
2001-03-22 |
2003-06-18 |
Solvay Pharmaceuticals B. V. |
4,5-Dihydro-1H-pyrazolové deriváty mající CB1-antagonistickou účinnost
|
|
WO2002078683A1
(en)
|
2001-03-29 |
2002-10-10 |
Synergy Pharmaceuticals, Inc. |
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
|
|
WO2001074782A1
(en)
|
2001-03-29 |
2001-10-11 |
Molecular Design International, Inc. |
β3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
|
|
GB0108631D0
(en)
|
2001-04-05 |
2001-05-30 |
Melacure Therapeutics Ab |
Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
|
|
CA2443672C
(en)
|
2001-04-12 |
2011-03-29 |
Pharmacopeia, Inc. |
Aryl and biaryl piperidines used as mch antagonists
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
|
US20040192673A1
(en)
|
2001-05-05 |
2004-09-30 |
Pascale Gaillard |
N-aroyl cyclic amine derivatives as orexin receptor antagonists
|
|
BR0209334A
(pt)
|
2001-05-05 |
2004-06-15 |
Smithkline Beecham Plc |
Aminas n-aroil cìclicas
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
|
AU2002338896B2
(en)
|
2001-05-21 |
2006-04-27 |
F.Hoffman-La Roche Ag |
Quinoline derivatives as ligands for the neuropeptide Y receptor
|
|
BR0209932A
(pt)
|
2001-05-22 |
2004-10-13 |
Neurogen Corp |
Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, preparação farmacêutica embalada, métodos para modular ligação de mch a um receptor de mch e de mvc, para alterar a atividade de transdução de sinal de um receptor de mch em uma célula, para tratar uma doença ou distúrbio associado com a ativação de receptor de mch patogênico obesidade e para determinar a presença ou ausência de receptor de mch em uma amostra, e, uso de um composto
|
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
WO2003000685A1
(fr)
|
2001-06-20 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Derives heterocycliques a 5 chainons
|
|
CA2450475A1
(en)
|
2001-06-20 |
2003-01-03 |
Linda Brockunier |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
EP1405636A4
(en)
|
2001-06-26 |
2009-04-15 |
Takeda Pharmaceutical |
FUNCTIONAL REGULATOR FOR RETINOID RELATIVE RECEPTOR
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
ATE380175T1
(de)
|
2001-06-27 |
2007-12-15 |
Smithkline Beecham Corp |
Pyrrolidine als dipeptidyl peptidase inhibitoren
|
|
ATE370943T1
(de)
|
2001-06-27 |
2007-09-15 |
Smithkline Beecham Corp |
Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
|
|
JP3909056B2
(ja)
|
2001-06-27 |
2007-04-25 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのフルオロピロリジン類
|
|
RU2299066C2
(ru)
|
2001-06-27 |
2007-05-20 |
Пробиодруг Аг |
Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов
|
|
JP2003018009A
(ja)
|
2001-06-29 |
2003-01-17 |
Mitsubishi Electric Corp |
デジタルアナログコンバータ
|
|
EP1404675B1
(en)
|
2001-07-03 |
2008-03-12 |
Novo Nordisk A/S |
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
|
|
WO2003005025A1
(en)
|
2001-07-03 |
2003-01-16 |
Biovitrum Ab |
Methods for identifying compounds modulating the activity of ppar-gamma
|
|
MXPA03011886A
(es)
|
2001-07-05 |
2005-03-07 |
Lundbeck & Co As H |
Piperidinias anilinicas sustituidas como antagonistas selectivos de mch.
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
ITMI20011483A1
(it)
|
2001-07-11 |
2003-01-11 |
Res & Innovation Soc Coop A R |
Uso di composti come antagonisti funzionali ai recettori centrali deicannabinoidi
|
|
WO2003006604A2
(en)
|
2001-07-12 |
2003-01-23 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
|
WO2003007949A1
(en)
|
2001-07-18 |
2003-01-30 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
|
WO2003007990A1
(en)
|
2001-07-18 |
2003-01-30 |
Sumitomo Pharmaceuticals Company, Limited |
Myosin agonist
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
AU2002355286B2
(en)
|
2001-07-26 |
2005-10-13 |
Schering Corporation |
Substituted urea neuropeptide Y Y5 receptor antagonists
|
|
JP4301940B2
(ja)
|
2001-07-31 |
2009-07-22 |
日清オイリオグループ株式会社 |
抗肥満剤およびその原料
|
|
GB0119172D0
(en)
|
2001-08-06 |
2001-09-26 |
Melacure Therapeutics Ab |
Phenyl pyrrole derivatives
|
|
WO2003014113A1
(en)
|
2001-08-06 |
2003-02-20 |
Glenmark Pharmaceuticals Limited |
Novel benzopyran compounds and process for their preparation and use
|
|
ATE427935T1
(de)
|
2001-08-07 |
2009-04-15 |
Banyu Pharma Co Ltd |
Spiro isobenzofurane als neuropeptid y rezeptor antagonisten
|
|
WO2003013574A1
(en)
|
2001-08-08 |
2003-02-20 |
Merck & Co., Inc. |
Melanin-concentrating hormone antagonists
|
|
US6911463B2
(en)
|
2001-08-14 |
2005-06-28 |
Eli Lilly And Company |
3-substituted oxindole β-3 agonists
|
|
DE60215028T2
(de)
|
2001-08-14 |
2007-03-15 |
Eli Lilly And Co., Indianapolis |
Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
|
|
WO2003015781A1
(en)
|
2001-08-15 |
2003-02-27 |
Sankyo Company, Limited |
Novel antidiabetic pharmaceutical compositions
|
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
SE0102764D0
(sv)
|
2001-08-17 |
2001-08-17 |
Astrazeneca Ab |
Compounds
|
|
US7371777B2
(en)
|
2001-08-17 |
2008-05-13 |
Eisai Co., Ltd. |
Cyclic compound and PPAR agonist
|
|
US20030092041A1
(en)
|
2001-08-23 |
2003-05-15 |
Millennium Pharmaceuticals, Inc. |
Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disorders
|
|
WO2003018010A1
(en)
|
2001-08-23 |
2003-03-06 |
Mitsubishi Pharma Corporation |
Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
|
|
JP2005507875A
(ja)
|
2001-08-31 |
2005-03-24 |
ユニバーシティ オブ コネチカット |
カンナビノイド受容体に作用する新規なピラゾール類似体
|
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
US6915444B2
(en)
|
2001-09-12 |
2005-07-05 |
Rockwell Automation Technologies, Inc. |
Network independent safety protocol for industrial controller using data manipulation techniques
|
|
CA2460578A1
(en)
|
2001-09-13 |
2003-03-27 |
Nisshin Pharma Inc. |
Propanolamine derivative having 1,4-benzodioxane ring
|
|
EP1430043A1
(en)
|
2001-09-14 |
2004-06-23 |
Bayer Pharmaceuticals Corporation |
Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
|
|
JP4619655B2
(ja)
|
2001-09-14 |
2011-01-26 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
|
|
TWI246510B
(en)
|
2001-09-14 |
2006-01-01 |
Mitsubishi Pharma Corp |
Thiazolidine derivatives and pharmaceutical uses thereof
|
|
EP1434765B1
(en)
|
2001-09-14 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
Substituted piperidines with selective binding to histamine h3-receptor
|
|
AU2002331311A1
(en)
|
2001-09-19 |
2003-04-01 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
WO2003024447A1
(en)
|
2001-09-20 |
2003-03-27 |
Smithkline Beecham Corporation |
Inhibitors of glycogen synthase kinase-3
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
CN101659639A
(zh)
|
2001-09-21 |
2010-03-03 |
索尔瓦药物有限公司 |
具有cb1-拮抗活性的新的4,5-二氢-1h-吡唑衍生物
|
|
TWI231757B
(en)
|
2001-09-21 |
2005-05-01 |
Solvay Pharm Bv |
1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
EP1295884A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives
|
|
KR100950430B1
(ko)
|
2001-09-21 |
2010-04-02 |
솔베이 파마슈티칼스 비. 브이 |
효력있는 ｃｂ1-길항 작용을 가지는4,5-디하이드로-1ｈ-피라졸 유도체
|
|
EP1295885A1
(en)
|
2001-09-21 |
2003-03-26 |
Sanofi-Synthelabo |
Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
|
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
|
WO2003026576A2
(en)
|
2001-09-24 |
2003-04-03 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Induction of brown adipocytes by transcription factor nfe2l2
|
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
|
EP1432708B1
(en)
|
2001-09-24 |
2005-11-30 |
Bayer Pharmaceuticals Corporation |
Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity
|
|
PE20030547A1
(es)
|
2001-09-24 |
2003-08-18 |
Bayer Corp |
Derivados de imidazol para el tratamiento de la obesidad
|
|
EP1585956A4
(en)
|
2001-09-24 |
2009-10-21 |
Univ Oregon Health & Science |
EVALUATION OF NEURONS IN THE NUCLEUS ARCUATUS FOR SCREENING ON THE ESSENTIAL CHANGING SUBSTANCES
|
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
|
BR0212829A
(pt)
|
2001-09-26 |
2004-08-03 |
Bayer Pharmaceuticals Corp |
Derivados de 1,8-naftiridina e seu uso para tratar diabetes e distúrbios relacionados
|
|
US20040191926A1
(en)
|
2001-09-26 |
2004-09-30 |
Zhong-Yin Zhang |
Ptp1b inhibitors and ligands
|
|
US6787558B2
(en)
|
2001-09-28 |
2004-09-07 |
Hoffmann-La Roche Inc. |
Quinoline derivatives
|
|
US7544690B2
(en)
|
2001-10-01 |
2009-06-09 |
Taisho Pharmaceutical Co., Ltd. |
MCH receptor antagonists
|
|
CA2462289C
(en)
|
2001-10-04 |
2010-02-23 |
Nicholas D. Cosford |
Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
|
|
US6667322B2
(en)
|
2001-10-05 |
2003-12-23 |
Wyeth |
Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
|
|
EP1434578A1
(en)
|
2001-10-09 |
2004-07-07 |
PHARMACIA & UPJOHN COMPANY |
Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands
|
|
US20030158209A1
(en)
|
2001-10-09 |
2003-08-21 |
Neurocrine Biosciences Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
|
US6573396B2
(en)
|
2001-10-12 |
2003-06-03 |
Exxonmobil Chemical Patents Inc. |
Co-production of dialkyl carbonates and diols with treatment of hydroxy alkyl carbonate
|
|
CA2463441A1
(en)
|
2001-10-12 |
2003-05-08 |
Bayer Pharmaceuticals Corporation |
Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
|
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
US20110105748A1
(en)
|
2001-10-16 |
2011-05-05 |
Debnath Bhuniya |
Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
|
|
JP2005509616A
(ja)
|
2001-10-16 |
2005-04-14 |
センジェント・セラピューティクス・インク |
チロシンホスファターゼに対する有機硫黄阻害剤
|
|
KR20050036876A
(ko)
|
2001-10-17 |
2005-04-20 |
노보 노르디스크 에이/에스 |
디카르복실산 유도체, 그것의 제제 및 치료에의 사용
|
|
US6596760B1
(en)
|
2001-10-18 |
2003-07-22 |
Merck & Co. Inc. |
Antidiabetic 4-hydroxy-2-furoic acids
|
|
EP1438044A1
(en)
|
2001-10-19 |
2004-07-21 |
Transtech Pharma, Inc. |
Bis-heteroaryl alkanes as therapeutic agents
|
|
TWI330183B
(pl)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
FR2831169B1
(fr)
|
2001-10-22 |
2003-12-12 |
Servier Lab |
Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
TWI301834B
(en)
|
2001-10-22 |
2008-10-11 |
Eisai R&D Man Co Ltd |
Pyrimidone compound and pharmaceutical composition including the same
|
|
DK1438045T3
(da)
|
2001-10-23 |
2007-06-11 |
Biovitrum Ab |
Anvendelse af indol- og indolin-derivater ved behandling af obesitet eller til reduktion af födeindtag
|
|
WO2003035602A1
(en)
|
2001-10-25 |
2003-05-01 |
Sankyo Company, Limited |
Lipid modulators
|
|
CZ2004634A3
(cs)
|
2001-10-25 |
2004-10-13 |
Takedaáchemicaláindustriesźáltd |
Chinolinová sloučeninaŹ způsob výroby a použití a farmaceutický přípravek
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
WO2003037864A1
(en)
|
2001-10-29 |
2003-05-08 |
Japan Tobacco Inc. |
Indole compound and medicinal use thereof
|
|
US7342117B2
(en)
|
2001-10-30 |
2008-03-11 |
Astellas Pharma Inc. |
α-form or β-form crystal of acetanilide derivative
|
|
AU2002363174B2
(en)
|
2001-11-01 |
2008-09-25 |
Janssen Pharmaceutica N.V. |
Amide derivatives as glycogen synthase kinase 3-beta inhibitors
|
|
IL161662A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors)
|
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
|
HUP0402245A3
(en)
|
2001-11-01 |
2010-03-29 |
Janssen Pharmaceutica Nv |
Pyrimidinyl-aminobenzamide derivatives as glycogen synthase kinase 3betha inhibitors, their use, pharmaceutical compositions containing them and process for producing them
|
|
US6673815B2
(en)
|
2001-11-06 |
2004-01-06 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
EP1450806B1
(en)
|
2001-11-09 |
2009-04-29 |
Biovitrum AB (publ) |
Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake
|
|
TW200303742A
(en)
|
2001-11-21 |
2003-09-16 |
Novartis Ag |
Organic compounds
|
|
AU2002365892A1
(en)
|
2001-11-30 |
2003-06-17 |
Merck & Co., Inc. |
Metabotropic glutamate receptor-5 modulators
|
|
HUP0402486A3
(en)
|
2001-11-30 |
2007-05-02 |
Lilly Co Eli |
Nitrogen containing heterocyclic compounds as peroxisome proliferator activated receptor agonists, their use and pharmaceutical compositions cointaining them
|
|
GB0128996D0
(en)
|
2001-12-04 |
2002-01-23 |
Novartis Ag |
Organic compounds
|
|
AU2002359580A1
(en)
|
2001-12-04 |
2003-07-24 |
Emory University |
Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
|
|
DE10160409A1
(de)
|
2001-12-10 |
2003-06-18 |
Guenther Beisel |
Verwendung von ionischen und nichtionischen Celluloseethern zur Herstellung eines gelartigen Mittels zur Verhinderung der Resorption von Fetten aus dem Magen-Darm-Trakt
|
|
MXPA04005427A
(es)
|
2001-12-10 |
2005-04-19 |
Amgen Inc |
Ligandos de receptor vainilloide y su uso en tratamientos.
|
|
EP1458708B1
(en)
|
2001-12-18 |
2007-09-26 |
Merck & Co., Inc. |
Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
|
|
JP4286146B2
(ja)
|
2001-12-18 |
2009-06-24 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−５のヘテロアリール置換ピラゾール系調節剤
|
|
EP1458385A4
(en)
|
2001-12-19 |
2005-12-21 |
Merck & Co Inc |
METABOTROPIC GLUTAMATE RECEPTOR 5-HETEROARYL-SUBSTITUTED IMIDAZOLE MODULATORS
|
|
JP4357965B2
(ja)
|
2001-12-21 |
2009-11-04 |
メルク エンド カムパニー インコーポレーテッド |
メタボトロピックグルタミン酸受容体−５のヘテロアリール置換ピロールモジュレーター
|
|
FR2833949B1
(fr)
|
2001-12-21 |
2005-08-05 |
Galderma Res & Dev |
NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
|
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
|
US20030129160A1
(en)
|
2002-01-09 |
2003-07-10 |
John-Olov Jansson |
Use of Interleukin-6
|
|
JP4733922B2
(ja)
|
2002-01-10 |
2011-07-27 |
インペリアル・イノベ−ションズ・リミテッド |
摂食行動の修正
|
|
JPWO2003059870A1
(ja)
|
2002-01-17 |
2005-05-19 |
塩野義製薬株式会社 |
Ｎ−置換スルフォンアミド誘導体およびそれを含有する糖尿病の予防または治療薬
|
|
AU2003245700A1
(en)
|
2002-02-12 |
2003-09-04 |
Glaxo Group Limited |
Pyrazolopyridine derivatives
|
|
WO2003072197A1
(en)
|
2002-02-27 |
2003-09-04 |
Pfizer Products Inc. |
Acc inhibitors
|
|
PT1485078E
(pt)
|
2002-03-15 |
2013-01-14 |
Cypress Bioscience Inc |
Milnacipran para o tratamento do síndrome do intestino irritável
|
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
|
SE0201175L
(sv)
|
2002-04-18 |
2003-10-19 |
Jonsered Cranes Ab |
Kranarrangemangstillhörig hållarenhet
|
|
US20050176746A1
(en)
|
2002-05-17 |
2005-08-11 |
Frank Weber |
Use of compounds that are effective as selective opiate receptor modulators
|
|
US20030226024A1
(en)
|
2002-06-04 |
2003-12-04 |
Qwest Communications International Inc. |
Secure internet documents
|
|
JP2006522817A
(ja)
|
2003-04-08 |
2006-10-05 |
プロジェニックス ファーマシューティカルズ，インコーポレーテッド |
過敏性腸症候群を処置するための末梢オピオイドアンタゴニスト、特にメチルナルトレキソンの使用
|
|
DE10331723A1
(de)
|
2003-07-11 |
2005-06-16 |
Merck Patent Gmbh |
Kappa-Agonisten
|
|
JP2008507280A
(ja)
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
ES2559840T3
(es)
|
2008-06-04 |
2016-02-16 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
JP5964589B2
(ja)
|
2008-12-03 |
2016-08-03 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼｃアゴニストの製剤およびその使用方法
|
|
CN102648207A
(zh)
*
|
2009-03-16 |
2012-08-22 |
马太克生物科学公司 |
在网粘菌门微生物中产生蛋白质
|
|
EP2621509A4
(en)
|
2010-09-15 |
2016-08-03 |
Synergy Pharmaceuticals Inc |
FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHOD OF USE
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
MX357121B
(es)
*
|
2011-03-01 |
2018-06-27 |
Synergy Pharmaceuticals Inc Star |
Proceso de preparacion de agonistas c de guanilato ciclasa.
|
|
PL3004138T3
(pl)
*
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
US9664598B2
(en)
|
2013-10-18 |
2017-05-30 |
Agilent Technologies, Inc. |
Microfluidic contaminant trap for trapping contaminants in gas chromatography
|